Biobanking for Medicine: Technology and Market 2012-2022

Biobanking for Medicine: Technology and Market 2012-2022


December 13, 2011
151 Pages - SKU: VSG6777442
License type:
Electronic Access - Single User Fulfilled By Publisher      US $2,633.00
Electronic Access - Departmental 1-5 Users      US $4,648.00
Electronic Access - Global Site License Fulfilled By Publisher      US $10,848.00
Biobanking for Medicine: Technology and Market 2012-2022

  enlarge


What does the future hold for biobanks? Visiongain's report shows you potential revenues and trends to 2022. Find data, forecasts and discussions for biobanking in medicine.

Discover sales predictions at overall market, submarket and national levels to 2022. Our study gives you business research, analysis and opinion for applications in medical research, pharmaceuticals and diagnostics.

How will the biobanking industry perform? Receive forecasts for human tissue banking, stem cell banking, private cord banking, other services (e.g., DNA and RNA storage), commercial biobanks, academic collections and other operations. You find revenues and discussions.

R&D applications are multiplying and widening. Assess contributions of biobanks in understanding disease, drug discovery, drug development and biomarkers. This decade will result in technological and organisational progress, public and private, benefiting healthcare.

Our report discusses Cryo-Cell International, Cord Blood America, Tissue Solutions, Asterand, ViaCord, LifebankUSA, China Cord Blood and other organisations. See activities and outlooks.

Biobanks and biorepositories will become more important to medical R&D and human healthcare. Biological science and technology stand to benefit. Discover the prospects.

Visiongain's study provides data, analysis and opinion aiming to help your research, calculations, meetings and presentations. You can find answers now in our work.

Revenue forecasts, market shares, developmental trends, discussions and interviews

In the report you find revenue forecasting, growth rates, market shares, qualitative analyses (incl. SWOT and STEP), news and views. You receive 72 tables and charts and six research interviews.

Advantages of Biobanking for Medicine: Technology and Market 2012-2022 for your work

In particular, this study gives you the following knowledge and benefits:
  • Find revenue predictions to 2022 for the overall world market and submarkets, seeing growth trends
  • Assess companies in medical biobanking, discovering activities and outlooks
  • See revenue forecasts to 2022 in leading countries for human tissue banking - US, Japan, Germany, France, UK, Spain, Italy, China and India
  • Review developmental trends for biobanks - technologies and services
  • Investigate competition and opportunities influencing commercial results
  • Find out what will stimulate and restrain that industry and market
  • View expert opinions from our survey of that biotechnology sector.
There, you receive a distinctive mix of quantitative and qualitative work with independent predictions. We analyse developments and prospects, helping you to stay ahead.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


Additional Information


Report Excerpt

7.2.1 Revenue Forecast for Stem Cell Banking Market, 2011-2016

The 2010 world market for stem cell biobanking generated $6.89bn. The strong demand for stem cells in the commercial, academic and private sectors will drive further revenue growth in this market for the forecast period. Sales are likely to reach $15.76bn by 2016, representing a CAGR of 14.8%.

Companies Listed

Abcellute
Abgene
Adnexus Therapeutics
AFNOR Groupe
AKH Biobank
AlloSource
American National Bioethics Advisory Commission
American Type Culture Collection
Amgen
Analytical Biological Services
ARCH Venture Partners
Asterand
AstraZeneca
Australasian Biospecimen Network (ABN)
Autoscribe
AXM Pharma
Bayer-Schering
Beckman Coulter
Beike Biotechnology
Biobank Ireland Trust
Biobank Japan
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)
BioFortis
Biogen Idec
Biogenea-CellGenea
BioLife Solutions
Biomatrica
Biopta
BioRep
BioSeek
BioServe
BioStorage LLC
BioStorage Technologies
BrainNet Europe
Caliper LifeSciences
Canadian Partnership for Tomorrow
CARTaGENE
Cellgene Corporation
Cells4Health
Chemagen
China Cord Blood Corp
Chinese Ministry of Health
CLB/Amsterdam Medical Center
CorCell
Cord Blood America
Cord Blood Registry
CORD:USE (US Public Cord Blood Bank)
CordLife
Cordon Vital (CBR)
Coriell Institute for Medical Research
Council of Europe (CoE)
Covance
Cryo Bio System
Cryo-Cell International
Cryometrix
Cryo-Save
Cureline
Cybrdi
Danubian Biobank Foundation
deCODE Genetics
Department of Health (DoH, UK)
Draper Laboratory
Duke University Medical Center
Dutch Collaborative Biobank
EGeen
Eli Lilly
Eolas Biosciences
Estonian Genome Project
EuroBioBank
European Commission (EC)
European Health Risk Monitoring (EHRM)
European Medicines Agency (EMA/EMEA)
European Union Group on Ethics (EGE)
Fisher BioServices
Fondazione I.R.C.C.S. Istituto Neurologico C. Besta
Food and Drug Administration (US FDA)
Foundation for the National Institutes of Health
Fundación Istituto Valenciano de Oncología
Fundeni Clinical Institute
Genentech
Generation Scotland
GeneSaver
GeneSys
Genetic Association Information Network (GAIN)
Genizon Biosciences
Genome Quebec Biobank
GenomEUtwin
Genomic Studies of Latvian Population
GenVault
German Dementia Competence Network
GlaxoSmithKline (GSK)
H. Lee Moffitt Cancer Center and Research Institute
Hamilton
Hopital Necker Paris - Necker DNA Bank
Human Tissue Authority (HTA)
Hungarian Biobank
HUNT, Norway
ILSBio LLC
Inbiobank
Inbiomed
Indivumed
INMEGEN
Institut National de la Santé et de la Recherche Médicale (INSERM)
Integrated BioBank of Luxembourg
International Agency for Research on Cancer (IARC)
International Air Transport Association (IATA)
International Organization for Standardization (ISO)
International Society for Biological and Environmental Repositories (ISBER)
International Stem Cell Corporation
Kaiser Permanente
KORA-gen
LabVantage Solutions
LabWare
Leiden University Medical Center
LifebankUSA
LifeGene
LifeStem
Malaysian Cohort Project
Matrical Biosciences
Matrix
Medical Research Council (MRC)
Medical University of Gdansk
Merck & Co.
Merck Sharp & Dohme Limited (MSD)
Merck-Serono
Micronic
Millennium (Takeda Oncology Company)
MVE-Chart
National Cancer Institute (NCI)
National DNA Bank (US)
National Human Genome Research Institute (NHGRI)
National Institute of Environmental Health
National Institutes of Health (NIH)
National Public Health Institute
National Research Ethics Service (NRES)
NeoCodex
NeoStem
Neuromuscular Bank of Tissues and DNA Samples
New Brunswick Scientific
NEXUS Biosystems
Northwest Regional Development Agency
Novacare Bio-Logistics
Novartis
NUgene Project
Ocimum Biosolutions
Office of Biorepositories and Biospecimen Research (OBBR)
OnCore UK
Organisation for Economic Co-operation and Development (OECD)
OriGene
Oxagen
Pacific Bio-Material Management
PathServe
Perkin Elmer
Pfizer
Pharmagene Laboratories Trustees Limited
Polaris Ventures
Pop-Gen (University Hospital Schleswig-Holstein)
PrecisionMed
Prevention Genetics
ProMedDx
Promoting Harmonisation of Epidemiological Biobanks in Europe (PHOEBE)
ProteoGenex
Public Population Projects in Genomics (P3G Consortium)
Qiagen
RAND Corporation
Regenetech
REMP
Reproductive Genetics Institute (RGI)
Research Centre of Vascular Diseases, University of Milan
Rhode Island BioBank, Brown University
Roche
RTS Life Science
Saga Investments LLC
SampleNavigator Laboratory Automation Systems
Sanofi
SANYO Biomedical
Scottish Government
Seattle Genetics
Sejtbank (Hungarian Cord Blood Bank)
SeqWright DNA Technology Services
SeraCare Life Sciences
Singapore Tissue Network
StarLIMS
Steelgate
Stem Cell Authority
Stem Cells for Safer Medicine (SC4SM)
Stem Cells Research Forum of India
Stemride International
Taiwan Biobank
Taizhou Biobank
TAP
Tecan
The Automation Partnership
The Sorenson Molecular Genealogy Foundation (SMGF)
Thermo Fisher Scientific
Thermogenesis
Tissue Bank Cryo Center (Bulgaria)
Tissue Solutions
Titan Pharmaceuticals
TotipotentSC
Trinity Biobank
Tumorothèque Necker-Entants Malades
UK Biobank
UK Stem Cell Bank
UmanGenomics
Umeå University
University Hospital Angers
University Medical Center Gent
University of Massachusetts Stem Cell Bank
University of Tuebingen, Department of Medical Genetics
US Biomax
Västerbotten County Council
ViaCord
Wellcome Trust
Wellcome Trust Case-Control Consortium (WTCCC)
Western Australian Genome Health Project
Wheaton Science International
Wisconsin International Stem Cell (WISC) Bank
World Health Organization (WHO)
Zhejiang Lukou Biotechnology Co